Fludrocortisone dose-response relationship in septic shock: a randomised phase II trial.

Saved in:
Bibliographic Details
Title: Fludrocortisone dose-response relationship in septic shock: a randomised phase II trial.
Authors: Walsham J; Princess Alexandra Hospital, Brisbane, Australia.; University of Queensland, Brisbane, Australia., Hammond N; The George Institute for Global Health, Sydney, Australia.; Royal North Shore Hospital, Sydney, Australia.; University of New South Wales, Sydney, Australia., Blumenthal A; University of Queensland, Brisbane, Australia., Cohen J; University of Queensland, Brisbane, Australia.; The Wesley Hospital, Brisbane, Australia.; Royal Brisbane Hospital, Brisbane, Australia., Myburgh J; The George Institute for Global Health, Sydney, Australia.; University of New South Wales, Sydney, Australia.; St. George Hospital, Sydney, Australia., Finfer S; The George Institute for Global Health, Sydney, Australia.; University of New South Wales, Sydney, Australia.; School of Public Health, Faculty of Medicine, Imperial College London, London, UK., Evans D; University of Queensland, Brisbane, Australia., Peake S; The Queen Elizabeth Hospital, Adelaide, SA, Australia.; University of Adelaide, Adelaide, Australia., Kruger P; Princess Alexandra Hospital, Brisbane, Australia.; University of Queensland, Brisbane, Australia., McCullough J; Gold Coast University Hospital, Gold Coast, QLD, Australia., Johnk L; Mater Hospital, Brisbane, Australia., Ghelani D; Blacktown Hospital, Sydney, Australia.; University of Sydney, Sydney, Australia.; Western Sydney University, Sydney, Australia., Billot L; The George Institute for Global Health, Sydney, Australia.; University of New South Wales, Sydney, Australia., Shan S; The George Institute for Global Health, Sydney, Australia., Meyer J; Princess Alexandra Hospital, Brisbane, Australia., Rajbhandari D; The George Institute for Global Health, Sydney, Australia., Koch C; The George Institute for Global Health, Sydney, Australia., Bellomo R; Austin Hospital, Melbourne, Australia.; Australia and New Zealand Research Centre, Melbourne, Australia.; Department of Medicine, University of Melbourne, Austin Health, Australia., Burrell LM; Austin Hospital, Melbourne, Australia.; Department of Medicine, University of Melbourne, Austin Health, Australia., Young M; Department of Medicine, University of Melbourne, Austin Health, Australia.; Baker Heart and Diabetes Institute, Melbourne, Australia., Roberts M; Therapeutics Research Centre, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Adelaide, Australia., Mackenzie L; Therapeutics Research Centre, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Adelaide, Australia.; University of South Australia, Adelaide, Australia., Medley G; University of Queensland, Brisbane, Australia., Dalton J; Therapeutics Research Centre, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Adelaide, Australia.; University of South Australia, Adelaide, Australia., Venkatesh B; The George Institute for Global Health, Sydney, Australia. bvenkatesh@georgeinstitute.org.au.; University of New South Wales, Sydney, Australia. bvenkatesh@georgeinstitute.org.au.; Gold Coast University Hospital, Gold Coast, QLD, Australia. bvenkatesh@georgeinstitute.org.au.
Source: Intensive care medicine [Intensive Care Med] 2024 Dec; Vol. 50 (12), pp. 2050-2060. Date of Electronic Publication: 2024 Sep 05.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Verlag Country of Publication: United States NLM ID: 7704851 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1238 (Electronic) Linking ISSN: 03424642 NLM ISO Abbreviation: Intensive Care Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-1238
DOI:10.1007/s00134-024-07616-z